METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat breast cancer? trial tests drug combo
Disease control CompletedThis study tested whether adding the drug veliparib to standard chemotherapy (cisplatin) helps people with advanced triple-negative or BRCA-related breast cancer, including those with brain tumors. About 344 participants were enrolled. The goal was to see if the combination could…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New hope for resistant breast cancer: bexarotene may Re-Sensitize tumors to chemo
Knowledge-focused CompletedThis early-phase study tested whether the drug bexarotene can change the behavior of triple-negative breast cancer cells that have stopped responding to taxane chemotherapy. The goal was to see if this change could make the cancer sensitive to chemotherapy again. Twelve women wit…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC